Home/Savara/Raymond J. Hage, Jr.
RJ

Raymond J. Hage, Jr.

Chief Executive Officer of Serendex Pharmaceuticals (subsidiary)

Savara

Savara Pipeline

DrugIndicationPhase
Molgramostim Nebulizer Solution (Molgradex®)Autoimmune Pulmonary Alveolar Proteinosis (aPAP)Phase 3
Molgramostim Nebulizer SolutionNon-tuberculous mycobacterial (NTM) Lung Infection in Cystic FibrosisPhase 2